purchasing agreement
Regeneron to Buy Out Libtayo From Sanofi
The transaction slated to close in Q3 will give Regeneron exclusive worldwide development, commercialization, and manufacturing rights.
Treadwell Therapeutics Acquires T Cell Therapy Firm TCRyption
With the acquisition, Treadwell expands its pipeline to include autologous cell therapies designed to target epitopes on cancer cells regardless of haplotype.
BioNTech to Acquire Gilead/Kite's TCR Therapy Program, Manufacturing Facility
The deal will give BioNTech a North American footprint while allowing Gilead subsidiary Kite to focus exclusively on commercializing its CAR T-cell therapies.